Login with your work email address to view charts. No credit card required.
| Art Unit: | 1611 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 604 — Surgery 602 — Surgery: splint, brace, or bandage 504 — Plant protecting and regulating compositions 370 — Multiplex communications 206 — Special receptacle or package |
| Phone: | (571) 272-0595 |
| Email: | isis.ghali@uspto.gov |
| Title: | Pat Examnr Biolgy |
| Service: | 27 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 23% over 290 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 92nd
|
With Examiner Ghali, you have a 23% chance of getting an issued patent by 3 years after the first office action. Examiner Ghali is an extremely hard examiner and in the 92nd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Ghali, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Ghali's grant rate is lower than that of Art Unit 1611 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Ghali | 2.8 |
| Art Unit 1611 | 1.7 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.